Open AccessPB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T‐ CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA
Author(s) -
Accorsi Buttini E.,
Farina M.,
Turra A.,
Morello E.,
Polverelli N.,
Colnaghi F.,
Almici C.,
Ferrari E.,
Bianchetti A.,
Leoni A.,
Re F.,
Bosio K.,
Bernardi S.,
Malagola M.,
Re A.,
Russo D.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851664.86963.2d
Subject(s) - medicine , cytokine release syndrome , diffuse large b cell lymphoma , rituximab , gastroenterology , cytopenia , lymphoma , chimeric antigen receptor , oncology , bone marrow , immunotherapy , cancer